S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The #1 Crypto for 2024 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

CymaBay Therapeutics (CBAY) Earnings Date, Estimates & Call Transcripts

→ 3 Sub-$10 Stocks to Buy for 2024 (From TradingTips) (Ad)
Free cbay Stock Alerts
$32.48
0.00 (0.00%)
(As of 04/1/2024)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Feb. 28)
-$0.35 Missed By -$0.04
Consensus EPS
(Feb. 28)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CBAY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CBAY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CymaBay Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.35)($0.23)($0.30)
Q2 20243($0.40)($0.24)($0.34)
Q3 20243($0.47)($0.24)($0.38)
Q4 20243($0.53)($0.24)($0.38)
FY 202412($1.75)($0.95)($1.41)

CBAY Earnings Date and Information

CymaBay Therapeutics last announced its earnings data on February 28th, 2024. The biopharmaceutical company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.31) by $0.04. The firm earned $0.06 million during the quarter, compared to analyst estimates of $0.42 million. CymaBay Therapeutics has generated ($0.97) earnings per share over the last year (($0.97) diluted earnings per share). Earnings for CymaBay Therapeutics are expected to grow in the coming year, from ($1.38) to ($1.37) per share. CymaBay Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

CymaBay Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)		------- 
2/28/2024Q4 2023($0.31)($0.35)($0.04)($0.35)$0.42 million$0.06 million
11/7/2023Q3 2023($0.30)($0.32)($0.02)($0.32)$0.22 million-    
8/10/2023Q2 2023($0.21)($0.01)+$0.20($0.01)$30.78 million$31.02 million    
5/15/2023Q1 2023($0.16)($0.29)($0.13)($0.29)--
3/16/2023Q4 2022($0.30)($0.30)-($0.30)--    
11/14/2022Q3 2022($0.30)($0.28)+$0.02($0.28)--
8/11/2022Q2 2022($0.30)($0.31)($0.01)($0.31)--    
5/12/2022Q1 2022($0.31)($0.32)($0.01)($0.32)--    
3/17/2022Q4 2021($0.36)($0.34)+$0.02($0.34)--    
11/10/2021Q3 2021($0.26)($0.33)($0.07)($0.33)--  
8/12/2021Q2 2021($0.27)($0.34)($0.07)($0.34)--    
5/13/2021Q1 2021($0.24)($0.25)($0.01)($0.25)--  

CymaBay Therapeutics Earnings - Frequently Asked Questions

When is CymaBay Therapeutics's earnings date?

CymaBay Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on CBAY's earnings history.

Did CymaBay Therapeutics beat their earnings estimates last quarter?

In the previous quarter, CymaBay Therapeutics (NASDAQ:CBAY) missed the analysts' consensus estimate of ($0.31) by $0.04 with a reported earnings per share (EPS) of ($0.35). Learn more on analysts' earnings estimate vs. CBAY's actual earnings.

How much revenue does CymaBay Therapeutics generate each year?

CymaBay Therapeutics (NASDAQ:CBAY) has a recorded annual revenue of $31.07 million.

How much profit does CymaBay Therapeutics generate each year?

CymaBay Therapeutics (NASDAQ:CBAY) has a recorded net income of -$105.37 million. CBAY has generated -$0.97 earnings per share over the last four quarters.

What is CymaBay Therapeutics's EPS forecast for next year?

CymaBay Therapeutics's earnings are expected to grow from ($1.38) per share to ($1.37) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:CBAY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends